U.S. Pharmaceuticals & Biotech Healthy potentially undervalued

Verastem

Market Cap: US$372.6m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Zevra Therapeutics

Market Cap: US$592.9m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Amphastar Pharmaceuticals

Market Cap: US$811.8m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Regeneron Pharmaceuticals

Market Cap: US$65.0b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

CorMedix

Market Cap: US$626.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Arcutis Biotherapeutics

Market Cap: US$2.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Caris Life Sciences

Market Cap: US$4.4b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Elanco Animal Health

Market Cap: US$10.9b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Tarsus Pharmaceuticals

Market Cap: US$2.7b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Journey Medical

Market Cap: US$164.1m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Fennec Pharmaceuticals

Market Cap: US$344.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Exagen

Market Cap: US$102.9m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Perrigo

Market Cap: US$1.6b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Abeona Therapeutics

Market Cap: US$310.1m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ADMA Biologics

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Qiagen

Market Cap: US$7.3b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Exelixis

Market Cap: US$12.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Viatris

Market Cap: US$19.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Vanda Pharmaceuticals

Market Cap: US$372.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

TG Therapeutics

Market Cap: US$5.5b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Protara Therapeutics

Market Cap: US$276.5m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Pacira BioSciences

Market Cap: US$918.8m

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Danaher

Market Cap: US$121.7b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

CareDx

Market Cap: US$1.1b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

Theravance Biopharma

Market Cap: US$843.9m

A biopharmaceutical company, develops and commercializes medicines in the United States.

Immunocore Holdings

Market Cap: US$1.5b

Engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.

Innoviva

Market Cap: US$1.7b

Operates as a biopharmaceutical company in the United States and internationally.

Supernus Pharmaceuticals

Market Cap: US$2.8b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Verrica Pharmaceuticals

Market Cap: US$104.1m

A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.

Coherus Oncology

Market Cap: US$248.3m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Azenta

Market Cap: US$930.2m

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Phibro Animal Health

Market Cap: US$1.3b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.